With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Achievement of first significant research milestone triggers an option exercise payment of $10 million from AstraZeneca <li /> AstraZen ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...